New product

Erivedge 150 mg (Vismodegib) 28 capsules

$17,000

ERIVEDGE 150 mg

28 capsules

Active ingredient:
  • Vismodegib 150 mg

Indications

Erivedge inhibits the hedgehog pathway and is used to treat adults with metastatic basal cell carcinoma. Erivedge is also used in patients with advanced local basal cell carcinoma recurring after surgery or in patients with this condition that are not eligible for surgery or radiation.

Contraindications

There are no contraindications for Erivedge.

Side Effects

Common side effects of Erivedge occurred in at least 10% of patients and include fatigue, alopecia, weight loss, vomiting, nausea, decreased appetite, diarrhea, constipation, ageusia, arthralgias, muscle spasms, and dysgeusia.

Manufacturer:

Roche Pharmaceuticals Ltd., Israel


DELIVERY WORLDWIDE


Also known as: Vismodegib

30 other products in the same category: